Cargando…
A new scaffold-free tumoroid model provides a robust preclinical tool to investigate invasion and drug response in Renal Cell Carcinoma
Clear cell Renal Cell Carcinoma (ccRCC) is one of the most prevalent kidney cancers, which is often asymptomatic and thus discovered at a metastatic state (mRCC). mRCC are highly heterogeneous tumors composed of subclonal populations that lead to poor treatment response rate. Several recent works ex...
Autores principales: | Séraudie, Irinka, Pillet, Catherine, Cesana, Beatrice, Bazelle, Pauline, Jeanneret, Florian, Evrard, Bertrand, Chalmel, Frédéric, Bouzit, Assilah, Battail, Christophe, Long, Jean-Alexandre, Descotes, Jean Luc, Cochet, Claude, Filhol, Odile |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517165/ https://www.ncbi.nlm.nih.gov/pubmed/37736770 http://dx.doi.org/10.1038/s41419-023-06133-z |
Ejemplares similares
-
Cooperative Blockade of CK2 and ATM Kinases Drives Apoptosis in VHL-Deficient Renal Carcinoma Cells through ROS Overproduction
por: Giacosa, Sofia, et al.
Publicado: (2021) -
COL7A1 Expression Improves Prognosis Prediction for Patients with Clear Cell Renal Cell Carcinoma Atop of Stage
por: Koca, Dzenis, et al.
Publicado: (2023) -
Ex-Vivo Treatment of Tumor Tissue Slices as a Predictive Preclinical Method to Evaluate Targeted Therapies for Patients with Renal Carcinoma
por: Roelants, Caroline, et al.
Publicado: (2020) -
CK2β Is a Gatekeeper of Focal Adhesions Regulating Cell Spreading
por: Filhol, Odile, et al.
Publicado: (2022) -
Human Metastatic Cholangiocarcinoma Patient-Derived Xenografts and Tumoroids for Preclinical Drug Evaluation
por: Serra-Camprubí, Queralt, et al.
Publicado: (2023)